| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Mar―10 |
Establishment and Evaluation of Human iPS Cell-Derived Myeloid Cell Lines Susceptible to SARS-CoV-2 |
Takayuki Hishiki, Yuka Yoshimura, Rieko Suzuki, Ami Murakami, Yua Saito, Naomi Tanga, et al. (+4) Jun Shimizu, Koichi Watashi, Tomohiko Takasaki, Kazuo Miyazaki |
| 2 |
[GO] |
2025―Sep―30 |
Molecular and Functional Characterization of Sika Deer ACE2 as a Receptor for SARS-CoV-2 |
Anastasiia Kovba, Manabu Igarashi, Keita Mizuma, Yuma Ohari, Manabu Onuma, Michito Shimozuru, et al. (+4) Kotaro Shimizu, Masami Yamanaka, Keita Matsuno, Toshio Tsubota |
| 3 |
[GO] |
2025―Aug―03 |
Screening and Characterization of B-Cell Epitopes of Porcine Respiratory Coronavirus Receptor Binding Domain Using Monoclonal Antibodies |
Aiping Wang, Jiachen Wang, Jingming Zhou, Yumei Chen, Hongliang Liu, Chao Liang, et al. (+5) Xifang Zhu, Enping Liu, Sixuan Wu, Yanhua Qi, Gaiping Zhang |
| 4 |
[GO] |
2025―Mar―12 |
Intranasal Administration of Bivalent RBD Nanoparticles Elicits Strong Systemic Responses That Effectively Block Distal Dissemination of COVID-19 |
Mathurin Seesen, Panya Sunintaboon, Jitra Limthongkul, Yada Janhirun, Hatairat Lerdsamran, Witthawat Wiriyarat, et al. (+2) Sukathida Ubol, Tuksin Jearanaiwitayakul |
| 5 |
[GO] |
2025―Jan―15 |
Diagnostic Markers of Severe COVID-19 and Community-Acquired Pneumonia in Children From Southern India |
Tina Damodar, Lonika Lodha, Sourabh Suran, Namratha Prabhu, Maria Jose, Uddhav Kinhal, et al. (+3) G. V. Basavaraja, Vykuntaraju K. Gowda, Reeta S. Mani |
| 6 |
[GO] |
2024―Nov―22 |
A Mouse Model of Ovalbumin-Induced Airway Allergy Exhibits Altered Localization of SARS-CoV-2-Susceptible Cells in the Lungs, Which Reflects Omicron BA.5 Infection Dynamics, Viral Mutations, and Immunopathology |
Takao Iketani, Kaya Miyazaki, Naoko Iwata-Yoshikawa, Yusuke Sakai, Nozomi Shiwa-Sudo, Seiya Ozono, et al. (+4) Hideki Asanuma, Hideki Hasegawa, Tadaki Suzuki, Noriyo Nagata |
| 7 |
[GO] |
2024―Sep―17 |
Development of a double-antibody sandwich ELISA for detection of SARS-CoV-2 variants based on nucleocapsid protein-specific antibodies |
Hai Lv, Fengjuan Shi, Huimin Yin, Yongjun Jiao, Pingmin Wei |
| 8 |
[GO] |
2024―Jul―04 |
Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant |
Shuhei Tsujino, Sayaka Deguchi, Tomo Nomai, Miguel Padilla-Blanco, Arnon Plianchaisuk, Lei Wang, et al. (+42) MST Monira Begum, Keiya Uriu, Keita Mizuma, Naganori Nao, Isshu Kojima, Tomoya Tsubo, Jingshu Li, Yasufumi Matsumura, Miki Nagao, Yoshitaka Oda, Masumi Tsuda, Yuki Anraku, Shunsuke Kita, Hisano Yajima, Kaori Sasaki-Tabata, Ziyi Guo, Alfredo A. Hinay, Kumiko Yoshimatsu, Yuki Yamamoto, Tetsuharu Nagamoto, Hiroyuki Asakura, Mami Nagashima, Kenji Sadamasu, Kazuhisa Yoshimura, Hesham Nasser, Michael Jonathan, Olivia Putri, Yoonjin Kim, Luo Chen, Rigel Suzuki, Tomokazu Tamura, Katsumi Maenaka, Takashi Irie, Keita Matsuno, Shinya Tanaka, Jumpei Ito, Terumasa Ikeda, Kazuo Takayama, Jiri Zahradnik, Takao Hashiguchi, Takasuke Fukuhara, Kei Sato |
| 9 |
[GO] |
2024―Jun―04 |
Involvement of SARS-CoV-2 accessory proteins in immunopathogenesis |
Hayato Ito, Tomokazu Tamura, Lei Wang, Kento Mori, Masumi Tsuda, Rigel Suzuki, et al. (+4) Saori Suzuki, Kumiko Yoshimatsu, Shinya Tanaka, Takasuke Fukuhara |
| 10 |
[GO] |
2024―Mar―06 |
N-glycosylation of the SARS-CoV-2 spike protein at Asn331 and Asn343 is involved in spike-ACE2 binding, virus entry, and regulation of IL-6 |
Tuhin Das, Shuhong Luo, Hao Tang, Jianmin Fang, Yinging Mao, Haw-Han Yen, et al. (+12) Sabyasachi Dash, Asif Shajahan, Lauren Pepi, Steven Huang, Valerie S. Jones, Shehuo Xie, Gordon F. Huang, Jinqiao Lu, Blake Anderson, Benyue Zhang, Parastoo Azadi, Ruo-Pan Huang |
| 11 |
[GO] |
2023―May―30 |
Capture and neutralization of SARS-CoV-2 and influenza virus by algae-derived lectins with high-mannose and core fucose specificities |
Tanuza Nazmul, Basirat M. Lawal-Ayinde, Tomoko Morita, Reiko Yoshimoto, Akifumi Higashiura, Akima Yamamoto, et al. (+7) Toshihito Nomura, Yukiko Nakano, Makoto Hirayama, Hiroshi Kurokawa, Yasuyuki Kitamura, Kanji Hori, Takemasa Sakaguchi |
| 12 |
[GO] |
2022―Oct―19 |
Smoking Enhances the Expression of Angiotensin-Converting Enzyme 2 Involved in the Efficiency of Severe Acute Respiratory Syndrome Coronavirus 2 Infection |
Rigel Suzuki, Yuki Ono, Koji Noshita, Kwang Su Kim, Hayato Ito, Yuhei Morioka, et al. (+8) Tomokazu Tamura, Daisuke Okuzaki, Tetsuzo Tagawa, Tomoyoshi Takenaka, Tomoharu Yoshizumi, Teppei Shimamura, Shingo Iwami, Takasuke Fukuhara |
| 13 |
[GO] |
2022―May―24 |
Prevalence of saliva immunoglobulin A antibodies reactive with severe acute respiratory syndrome coronavirus 2 among Japanese people unexposed to the virus |
Keiichi Tsukinoki, Tetsuro Yamamoto, Jiro Saito, Wakako Sakaguchi, Keiichiro Iguchi, Yoshinori Inoue, et al. (+14) Shigeru Ishii, Chikatoshi Sato, Mina Yokoyama, Yuki Shiraishi, Noriaki Kato, Hiroyasu Shimada, Akio Makabe, Akihiro Saito, Masanori Tanji, Isao Nagaoka, Juri Saruta, Tetsutaro Yamaguchi, Shigenari Kimoto, Hideyo Yamaguchi |
| 14 |
[GO] |
2022―Mar―29 |
Targeting of neutrophil activation in the early phase of the disease for prevention of Coronavirus disease-19 severity |
Fujiro Sendo, Hiroshi Yoshitake, Yoshihiko Araki |
| 15 |
[GO] |
2022―Jan―10 |
Viral shedding and the durability of IgG antibodies to SARS-CoV-2 |
Maria Inge Lusida, Emily Gunawan, Ni Luh Ayu Megasari, Laura Navika Yamani, Takako Utsumi, Yasuko Mori |
| 16 |
[GO] |
2021―Sep―25 |
Proteolytic activation of SARS-CoV-2 spike protein |
Makoto Takeda |
| 17 |
[GO] |
2021―Apr―09 |
Multiple clades of SARS-CoV-2 were introduced to Thailand during the first quarter of 2020 |
Rome Buathong, Walairat Chaifoo, Sopon Iamsirithawon, Supaporn Wacharapluesadee, Yutthana Joyjinda, Apaporn Rodpan, et al. (+12) Weenassarin Ampoot, Opass Putcharoen, Leilani Paitoonpong, Gompol Suwanpimolkul, Watsamon Jantarabenjakul, Sininat Petcharat, Saowalak Bunprakob, Siriporn Ghai, Wisit Prasithsirikul, Anek Mungaomklang, Tanarak Plipat, Thiravat Hemachudha |
| 18 |
[GO] |
2020―Nov―24 |
Reduction of Severe Acute Respiratory Syndrome Coronavirus-2 Infectivity by Admissible Concentration of Ozone Gas and Water |
Takayuki Murata, Satoshi Komoto, Satoko Iwahori, Jun Sasaki, Hironori Nishitsuji, Terumitsu Hasebe, et al. (+2) Kiyotaka Hoshinaga, Yukio Yuzawa |
| 19 |
[GO] |
2020―Jun―24 |
Antiviral activities of mycophenolic acid and IMD-0354 against SARS-CoV-2 |
Fumihiro Kato, Shutoku Matsuyama, Miyuki Kawase, Takayuki Hishiki, Hiroshi Katoh, Makoto Takeda |
|
